Johnson & Johnson in a free fall - Analysis - 31-01-2023

Economies.com
4 months ago

Johnson & Johnson's stock (JNJ) skidded in the intraday levels after the Wall Street Journal said the US Appeals Court refused its consumer products suit, sending its stock down 3.70% in the last session, or 6.23 points, settling at 162.00, with trading volumes surpassing 23.2 million shares, above 10-day averages of 9 million shares. 

 

Technically, the stock suffers from the dominance of the downward correctional trend in the short term, with negative pressure from the 50-day SMA, countered with positive signals from the RSI after reaching oversold levels. 

 

Therefore we expect more losses for the stock, targeting the first support at 159.18, provided it settles below 167.70. 

 

Expected trend for today: Bearish

Stocks Technical Analysis

United States Analysis

Stocks

United Health collects profits - Analysis - 06-06-2023
20 hours ago
United Health Group Incorporated's stock (UNH) fell in the intraday levels on profit-taking, while ...
United States Analysis

Stocks

Bank of America gathers positive momentum - Analysis - 06-06-2023
20 hours ago
Bank of America's stock (BAC) fell in the intraday levels, while gathering positive momentum to ...
United States Analysis

Stocks

Bristol-Myers Squibb tries to correct downward trend - Analysis - 06-06-2023
20 hours ago
Bristol-Myers Squibb Company's stock (BMY) rose in the intraday levels, buoyed by positive signals ...